Chemoinformaics analysis of N-methylcoclaurine
| Molecular Weight | 299.37 | nRot | 3 |
| Heavy Atom Molecular Weight | 278.202 | nRig | 17 |
| Exact Molecular Weight | 299.152 | nRing | 3 |
| Solubility: LogS | -1.809 | nHRing | 1 |
| Solubility: LogP | 2.186 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 47.5687 |
| nHD | 2 | BPOL | 24.5133 |
| QED | 0.915 |
| Synth | 2.705 |
| Natural Product Likeliness | 1.186 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.112 |
| HIA | 0.006 |
| CACO-2 | -4.603 |
| MDCK | 0.0000128 |
| BBB | 0.972 |
| PPB | 0.675563 |
| VDSS | 2.116 |
| FU | 0.246307 |
| CYP1A2-inh | 0.261 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.192 |
| CYP2c19-sub | 0.853 |
| CYP2c9-inh | 0.028 |
| CYP2c9-sub | 0.786 |
| CYP2d6-inh | 0.678 |
| CYP2d6-sub | 0.931 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.855 |
| CL | 17.226 |
| T12 | 0.871 |
| hERG | 0.584 |
| Ames | 0.306 |
| ROA | 0.575 |
| SkinSen | 0.917 |
| Carcinogencity | 0.097 |
| EI | 0.013 |
| Respiratory | 0.691 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.681541 |